Patent · US Expired

Treating degenerative joint disorders with tribonectins

US7618941B2 · kind B2 · utility

16Cited by
23References
29Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 1, 2004
Grant dateNov 17, 2009
Priority date
Expiry dateFeb 23, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.